News | Mammography | October 01, 2015

Hologic, Kristin Chenoweth Ring Nasdaq Opening Bell for Breast Cancer Awareness Month

Award-winning singer and actress will lead national campaign to increase insurance coverage for Hologic’s Genius 3D Mammography exams

X0000_Hologic_Nasdaq_opening_bell_2015.jpg

Image courtesy of Hologic

October 1, 2015 — Hologic Inc. President and CEO Steve MacMillan was joined by award-winning actress and singer Kristin Chenoweth in ringing the Nasdaq Opening Bell on October 1, the first day of Breast Cancer Awareness Month.

This is the 10th year in a row that Nasdaq has invited Hologic to preside over its Opening Bell ceremony to kick off Breast Cancer Awareness Month.

MacMillan spoke during the ceremony about Hologic’s Genius 3D Mammography technology, which clinical studies have shown is more accurate than traditional 2-D mammograms alone. The Genius exam reduces callbacks by up to 40 percent, and detect 41 percent more invasive cancers than 2-D screenings.

During Breast Cancer Awareness Month, Chenoweth will serve as spokeswoman for a national campaign to encourage insurance companies to cover Genius 3D Mammography exams. Chenoweth is the daughter of a two-time breast cancer survivor. As part of the campaign, she will conduct interviews throughout October with national and regional media outlets. In addition, a social media campaign will include the support of additional high-profile celebrities.

The Genius 3D Mammography exam is U.S. Food and Drug Administration (FDA)-approved and available on the Hologic Selenia Dimensions system. 

For more information: www.hologic.com

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init